Cargando…

Structure-Based Understanding of Binding Affinity and Mode of Estrogen Receptor α Agonists and Antagonists

The flexible hydrophobic ligand binding pocket (LBP) of estrogen receptor α (ERα) allows the binding of a wide variety of endocrine disruptors. Upon ligand binding, the LBP reshapes around the contours of the ligand and stabilizes the complex by complementary hydrophobic interactions and specific hy...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Sehan, Barron, Mace G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5218732/
https://www.ncbi.nlm.nih.gov/pubmed/28061508
http://dx.doi.org/10.1371/journal.pone.0169607
_version_ 1782492332277366784
author Lee, Sehan
Barron, Mace G.
author_facet Lee, Sehan
Barron, Mace G.
author_sort Lee, Sehan
collection PubMed
description The flexible hydrophobic ligand binding pocket (LBP) of estrogen receptor α (ERα) allows the binding of a wide variety of endocrine disruptors. Upon ligand binding, the LBP reshapes around the contours of the ligand and stabilizes the complex by complementary hydrophobic interactions and specific hydrogen bonds with the ligand. Here we present a framework for quantitative analysis of the steric and electronic features of the human ERα-ligand complex using three dimensional (3D) protein-ligand interaction description combined with 3D-QSAR approach. An empirical hydrophobicity density field is applied to account for hydrophobic contacts of ligand within the LBP. The obtained 3D-QSAR model revealed that hydrophobic contacts primarily determine binding affinity and govern binding mode with hydrogen bonds. Several residues of the LBP appear to be quite flexible and adopt a spectrum of conformations in various ERα-ligand complexes, in particular His524. The 3D-QSAR was combined with molecular docking based on three receptor conformations to accommodate receptor flexibility. The model indicates that the dynamic character of the LBP allows accommodation and stable binding of structurally diverse ligands, and proper representation of the protein flexibility is critical for reasonable description of binding of the ligands. Our results provide a quantitative and mechanistic understanding of binding affinity and mode of ERα agonists and antagonists that may be applicable to other nuclear receptors.
format Online
Article
Text
id pubmed-5218732
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-52187322017-01-19 Structure-Based Understanding of Binding Affinity and Mode of Estrogen Receptor α Agonists and Antagonists Lee, Sehan Barron, Mace G. PLoS One Research Article The flexible hydrophobic ligand binding pocket (LBP) of estrogen receptor α (ERα) allows the binding of a wide variety of endocrine disruptors. Upon ligand binding, the LBP reshapes around the contours of the ligand and stabilizes the complex by complementary hydrophobic interactions and specific hydrogen bonds with the ligand. Here we present a framework for quantitative analysis of the steric and electronic features of the human ERα-ligand complex using three dimensional (3D) protein-ligand interaction description combined with 3D-QSAR approach. An empirical hydrophobicity density field is applied to account for hydrophobic contacts of ligand within the LBP. The obtained 3D-QSAR model revealed that hydrophobic contacts primarily determine binding affinity and govern binding mode with hydrogen bonds. Several residues of the LBP appear to be quite flexible and adopt a spectrum of conformations in various ERα-ligand complexes, in particular His524. The 3D-QSAR was combined with molecular docking based on three receptor conformations to accommodate receptor flexibility. The model indicates that the dynamic character of the LBP allows accommodation and stable binding of structurally diverse ligands, and proper representation of the protein flexibility is critical for reasonable description of binding of the ligands. Our results provide a quantitative and mechanistic understanding of binding affinity and mode of ERα agonists and antagonists that may be applicable to other nuclear receptors. Public Library of Science 2017-01-06 /pmc/articles/PMC5218732/ /pubmed/28061508 http://dx.doi.org/10.1371/journal.pone.0169607 Text en https://creativecommons.org/publicdomain/zero/1.0/ This is an open access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 (https://creativecommons.org/publicdomain/zero/1.0/) public domain dedication.
spellingShingle Research Article
Lee, Sehan
Barron, Mace G.
Structure-Based Understanding of Binding Affinity and Mode of Estrogen Receptor α Agonists and Antagonists
title Structure-Based Understanding of Binding Affinity and Mode of Estrogen Receptor α Agonists and Antagonists
title_full Structure-Based Understanding of Binding Affinity and Mode of Estrogen Receptor α Agonists and Antagonists
title_fullStr Structure-Based Understanding of Binding Affinity and Mode of Estrogen Receptor α Agonists and Antagonists
title_full_unstemmed Structure-Based Understanding of Binding Affinity and Mode of Estrogen Receptor α Agonists and Antagonists
title_short Structure-Based Understanding of Binding Affinity and Mode of Estrogen Receptor α Agonists and Antagonists
title_sort structure-based understanding of binding affinity and mode of estrogen receptor α agonists and antagonists
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5218732/
https://www.ncbi.nlm.nih.gov/pubmed/28061508
http://dx.doi.org/10.1371/journal.pone.0169607
work_keys_str_mv AT leesehan structurebasedunderstandingofbindingaffinityandmodeofestrogenreceptoraagonistsandantagonists
AT barronmaceg structurebasedunderstandingofbindingaffinityandmodeofestrogenreceptoraagonistsandantagonists